GWM
MDT icon

Graybill Wealth Management’s Medtronic MDT Stock Holding History

Graybill Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$352K Hold
4,061
– – 0.11% 69
2025
Q4 		$390K Hold
4,061
– – 0.12% 68
2025
Q3 		$387K Hold
4,061
– – 0.12% 67
2025
Q2 		$354K Sell
4,061
-100
-2% -$8.48K 0.12% 71
2025
Q1 		$374K Buy
+4,161
New +$372K 0.13% 66

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Graybill Wealth Management's MDT Position: Q1 2026 in Review

Graybill Wealth Management held its Medtronic (MDT) position steady in Q1 2026 at 4,061 shares worth $352K. The position accounts for 0.11% of the portfolio, ranked #69.

Graybill Wealth Management first reported a position in MDT in Q1 2025 and has held it in 5 quarters since. The position peaked at $390K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Graybill Wealth Management held 4,061 shares of Medtronic worth $352K as of Q1 2026.
  • Graybill Wealth Management left its Medtronic share count unchanged in Q1 2026.
  • Medtronic made up 0.11% of Graybill Wealth Management's portfolio in Q1 2026, its #69 holding.
  • Graybill Wealth Management first reported a position in Medtronic in Q1 2025 and has held it in 5 quarters since.
  • Graybill Wealth Management's Medtronic position peaked at $390K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Graybill Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.